I sold at a small gain. Too volatile for my blood. But will watch to see how it stabilizes and makes a new base. Unlikely to have a V bottom unless there is some positive news.
this is good , constructive consolidation action. I agree a marginal new high or flat for the day. We should see 30 -31 this week in my opinion.
I like ADXS, but no one knows what its true value should be. this stock could be great for the long term but this along with most other biotechs will need some time to base. I expect the next up move after the conference in Chicago at the end of May. Technically I will buy more at 16.50, not for a trade but to hold for the long term.
I am long ADXS since just this past Monday morning, when it wiped out the morning loss. I have been following this stock for a long time since late December. This is my second time around owning ADXS. first it was from 6.50 to 11, and then I watched it fall back to 7 followed by the tremendous rise. I do not know how long I will be a holder of this stock as it is truly a spec at this point. As a trader, it is good to cover your bait and let the profits run. I am not a basher like boka_raton but there is some wisdom about understanding the risk level in biotech which are dependent on binary outcomes. So far so good and I think ADXS has real potential. One other thing, my thoughts about the timing of the secondary will be towards end of May after ADXS has announced positive progress at the big Chicago Immunotherapy conference. Just my guess. If Adage does most of this secondary then I will have even more confidence on the long term value proposition.
could there be a secondary offering coming soon? I would doubt it since it went public in mid December and there has been no real price appreciation. Thoughts?
It is amazing how this stock moves up and down in a $3 dollar range so quickly and easily. Maybe we need a bigger float. It seems to have decouple from JUNO, although that is down also on profit taking.
I can't seem to make sense of this stock. It seems like day traders get in an out. I thought yesterday's big volume would have cleaned out the weak holders. It is options expiration but BLCM has very little open interest. On 10,000 shares the stock can have big swings. in the bio space I have two stocks JUNO and BLCM I expect to get doubles in them in the next 12 months.
i know the guy at NVS who is following this space, he likes BLCM, JUNO and KITE in that order. No discussion or knowledge of a possible partnership.
management who participate in these plans cannot just arbitrarily stop selling their shares even if good news might be coming. If they stopped the selling and a takeover happened the management would be blamed for inside information. My guess is that insider sales will have minor to no effect on the bullish chart of ACHN
Usually a print like that means that 14.92 was the average price paid for shares bought during the day but printed at the end of day. Still significant as it was one buyer-GILD?
For me the key reason to own the stock is the significant ownership by Adage in ADXS. They would not be involved in a fraud and they obviously see the potential in their scientific approach. So far no insider has sold despite the recent run up (usually insiders sell if they see a steep price increase. A lot of recent hot "bio names like BLCM, Juno, etc have had corrections. I would not bet against Adage!!!
It is not the end of the world they have at least 10 major portfolios. Adaptix is one of them, but I would expect for Acacia to refile as this is just a summary decision and not a jury verdict.
A good short never advertises. As long as we have big volume the bulls will win. On low volume the shorts can manipulate. I think 15 is in the bag for next week if the overall market is flat to positive.
I was at the Pats game last night, miserable weather but a great performance by defense and offense. We will beat Seattle as their offense is one dimensional (run) and the defense is good but the Pats offense is better (IMO). I think the Pats win 24-13.
Good chance that Lance Shaner will take the company private if he can work something with the debt holders.